Skip to main content

Find Clinical Trials

Home
Conditions
Opioid Dependence

Clinical trial condition

Opioid Dependence

Explore clinical trials studying Opioid Dependence. Study availability and eligibility vary by location and protocol.

123 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Opioid Dependence trial results

Completed

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

NCT02357901

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
Locations: Haleyville Clinical Research Haleyville, Alabama, United States

Boyett Health Services Hamilton, Alabama, United States

Woodland International Research Group Little Rock, Arkansas, United States

Collaborative Neuroscience Network Garden Grove, California, United States

View all 38 locations

View Trial Details

Completed

Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2

NCT00249457

Conditions: Behavior, Behavior, Addictive, Chemically-Induced Disorders, +11 more
Locations: The Center for Learning and Health Baltimore, Maryland, United States

View Trial Details

Completed

Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients

NCT01650649

Conditions: Chemically-Induced Disorders, Mental Disorders, Methadone Withdrawal Syndrome, +4 more
Locations: Lifetree Clinical Research Salt Lake City, Utah, United States

View Trial Details

Completed

Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy

NCT02243670

Conditions: Addiction, Behavior, Behavior, Addictive, +16 more
Locations: Montefiore Medical Center New York, United States

View Trial Details

Completed

Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance

NCT01642030

Conditions: Addiction, Behavior, Behavior, Addictive, +12 more
Locations: Behavioral Pharmacology Research Unit Baltimore, Maryland, United States

View Trial Details

Completed

Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers

NCT01740414

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +8 more
Locations: New York State Psychiatric Institute New York, United States

View Trial Details

Completed

Medications Development for Drug Abuse Disorders

NCT01188421

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +5 more
Locations: Johns Hopkins University (BPRU) Bayview Campus Baltimore, Maryland, United States

View Trial Details

Completed

Improving Buprenorphine Detoxification Outcomes With Isradipine

NCT01895270

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: UAMS Psychiatric Research Institute Little Rock, Arkansas, United States

View Trial Details

Completed

An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects

NCT01666119

Conditions: Behavior, Behavior, Addictive, Chemically-Induced Disorders, +7 more
Locations: Birmingham, Alabama, United States

Haleyville, Alabama, United States

Jacksonville, Florida, United States

Maitland, Florida, United States

View Trial Details

Completed

Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population

NCT02038790

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: Hill Top Research St. Petersburg, Florida, United States

View Trial Details